Catalysts for $TAK
4 tracked
May 13, 2026
earnings
TAKEDA PHARMACEUTICAL CO LTD earnings
TAKEDA PHARMACEUTICAL CO LTD
→
Apr 30, 2026
phase 1 completion
Takeda Pharmaceutical Co Ltd — Cabometyx (Phase I Trial Completion)
cabozantinib s-malate
→
Feb 4, 2026
recall
Sato Pharmaceutical Co., Ltd recall (Cls II)
TAKEDA PHARMACEUTICAL CO LTD
→
Jul 18, 2025
device 510k
Takeda Pharmaceuticals — HyHub and HyHub Duo Vial Access Devices (510k cleared)
TAKEDA PHARMACEUTICAL CO LTD
→